Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma.

Maity TK, Venugopalan A, Linnoila I, Cultraro CM, Giannakou A, Nemati R, Zhang X, Webster JD, Ritt D, Ghosal S, Hoschuetzky H, Simpson RM, Biswas R, Politi K, Morrison DK, Varmus HE, Guha U.

Cancer Discov. 2015 May;5(5):534-49. doi: 10.1158/2159-8290.CD-14-0750. Epub 2015 Mar 3.

2.

ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages.

Zhang Y, Choksi S, Chen K, Pobezinskaya Y, Linnoila I, Liu ZG.

Cell Res. 2013 Jul;23(7):898-914. doi: 10.1038/cr.2013.75. Epub 2013 Jun 11.

3.

Epstein-Barr virus microRNAs and lung cancer.

Koshiol J, Gulley ML, Zhao Y, Rubagotti M, Marincola FM, Rotunno M, Tang W, Bergen AW, Bertazzi PA, Roy D, Pesatori AC, Linnoila I, Dittmer D, Goldstein AM, Caporaso NE, McShane LM, Wang E, Landi MT.

Br J Cancer. 2011 Jul 12;105(2):320-6. doi: 10.1038/bjc.2011.221. Epub 2011 Jun 7.

4.

MicroRNA expression differentiates histology and predicts survival of lung cancer.

Landi MT, Zhao Y, Rotunno M, Koshiol J, Liu H, Bergen AW, Rubagotti M, Goldstein AM, Linnoila I, Marincola FM, Tucker MA, Bertazzi PA, Pesatori AC, Caporaso NE, McShane LM, Wang E.

Clin Cancer Res. 2010 Jan 15;16(2):430-41. doi: 10.1158/1078-0432.CCR-09-1736. Epub 2010 Jan 12.

5.

Environment And Genetics in Lung cancer Etiology (EAGLE) study: an integrative population-based case-control study of lung cancer.

Landi MT, Consonni D, Rotunno M, Bergen AW, Goldstein AM, Lubin JH, Goldin L, Alavanja M, Morgan G, Subar AF, Linnoila I, Previdi F, Corno M, Rubagotti M, Marinelli B, Albetti B, Colombi A, Tucker M, Wacholder S, Pesatori AC, Caporaso NE, Bertazzi PA.

BMC Public Health. 2008 Jun 6;8:203. doi: 10.1186/1471-2458-8-203.

6.

Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis.

Deeb KK, Michalowska AM, Yoon CY, Krummey SM, Hoenerhoff MJ, Kavanaugh C, Li MC, Demayo FJ, Linnoila I, Deng CX, Lee EY, Medina D, Shih JH, Green JE.

Cancer Res. 2007 Sep 1;67(17):8065-80. Erratum in: Cancer Res. 2007 Oct 15;67(20):10097.

7.

Tobacco carcinogen-induced cellular transformation increases Akt activation in vitro and in vivo.

West KA, Linnoila IR, Brognard J, Belinsky S, Harris C, Dennis PA.

Chest. 2004 May;125(5 Suppl):101S-2S. No abstract available.

PMID:
15136436
8.
9.

Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells.

West KA, Brognard J, Clark AS, Linnoila IR, Yang X, Swain SM, Harris C, Belinsky S, Dennis PA.

J Clin Invest. 2003 Jan;111(1):81-90.

10.

Microvessel density, expression of estrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast cancer.

McCarthy NJ, Yang X, Linnoila IR, Merino MJ, Hewitt SM, Parr AL, Paik S, Steinberg SM, Hartmann DP, Mourali N, Levine PH, Swain SM.

Clin Cancer Res. 2002 Dec;8(12):3857-62.

12.

Neuroendocrine-specific protein (NSP)-reticulons as independent markers for non-small cell lung cancer with neuroendocrine differentiation. An in vitro histochemical study.

Senden N, Linnoila I, Timmer E, van de Velde H, Roebroek A, Van de Ven W, Broers J, Ramaekers F.

Histochem Cell Biol. 1997 Aug;108(2):155-65.

PMID:
9272435
13.

Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome.

Foss FM, Ihde DC, Linnoila IR, Fischmann AB, Schechter GP, Cotelingam JD, Steinberg SM, Ghosh BC, Stocker JL, Bastian A, et al.

J Clin Oncol. 1994 Oct;12(10):2051-9.

PMID:
7931473
14.

Lung endocrine cell markers, peptides, and amines.

Polak JM, Becker KL, Cutz E, Gail DB, Goniakowska-Witalinska L, Gosney JR, Lauweryns JM, Linnoila I, McDowell EM, Miller YE, et al.

Anat Rec. 1993 May;236(1):169-71. No abstract available.

PMID:
8507003
15.

Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome.

Foss FM, Ihde DC, Breneman DL, Phelps RM, Fischmann AB, Schechter GP, Linnoila I, Breneman JC, Cotelingam JD, Ghosh BC, et al.

J Clin Oncol. 1992 Dec;10(12):1907-13.

PMID:
1453206
16.

Thymic carcinoid in association with MEN syndromes.

Zeiger MA, Swartz SE, MacGillivray DC, Linnoila I, Shakir M.

Am Surg. 1992 Jul;58(7):430-4. Review.

PMID:
1352092
17.

Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions.

Takahashi T, Carbone D, Takahashi T, Nau MM, Hida T, Linnoila I, Ueda R, Minna JD.

Cancer Res. 1992 Apr 15;52(8):2340-3.

18.

Nonrandom structural and numerical chromosome changes in non-small-cell lung cancer.

Whang-Peng J, Knutsen T, Gazdar A, Steinberg SM, Oie H, Linnoila I, Mulshine J, Nau M, Minna JD.

Genes Chromosomes Cancer. 1991 May;3(3):168-88.

PMID:
1651103
19.

Pathology of non-small cell lung cancer. New diagnostic approaches.

Linnoila I.

Hematol Oncol Clin North Am. 1990 Dec;4(6):1027-51. Review.

PMID:
1962774
20.

Mucinous cystadenoma of the lung. A report of two cases with immunohistochemical and ultrastructural analysis.

Kragel PJ, Devaney KO, Meth BM, Linnoila I, Frierson HF Jr, Travis WD.

Arch Pathol Lab Med. 1990 Oct;114(10):1053-6.

PMID:
1699507
21.

Electron microscopic localization of enkephalin-like immunoreactivity in the human adrenal medulla.

Hervonen A, Linnoila I, Vaalasti A, Alho H, Pelto-Huikko M.

J Electron Microsc Tech. 1989 Aug;12(4):380-8.

PMID:
2769437
22.

Substance P: the relationship between receptor distribution in rat lung and the capacity of substance P to stimulate vascular permeability.

Sertl K, Wiedermann CJ, Kowalski ML, Hurtado S, Plutchok J, Linnoila I, Pert CB, Kaliner MA.

Am Rev Respir Dis. 1988 Jul;138(1):151-9.

PMID:
2462377
23.

Monoclonal antibodies for the in vitro detection of small cell lung cancer metastases in human bone marrow.

Lebacq-Verheyden AM, Neirynck A, Ravoet AM, Humblet Y, Oie H, Linnoila I, Gazdar AF, Minna JD, Symann M.

Eur J Cancer Clin Oncol. 1988 Feb;24(2):137-45.

PMID:
2833399
24.

Gastrin-releasing peptide and other autocrine growth factors in lung cancer: pathogenetic and treatment implications.

Minna JD, Cuttitta F, Battey JF, Mulshine JL, Linnoila I, Gazdar AF, Trepel J, Sausville EA.

Important Adv Oncol. 1988:55-64. Review. No abstract available.

PMID:
3042610
25.

Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene.

Johnson BE, Battey J, Linnoila I, Becker KL, Makuch RW, Snider RH, Carney DN, Minna JD.

J Clin Invest. 1986 Aug;78(2):525-32.

27.

Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer.

Doyle A, Martin WJ, Funa K, Gazdar A, Carney D, Martin SE, Linnoila I, Cuttitta F, Mulshine J, Bunn P, et al.

J Exp Med. 1985 May 1;161(5):1135-51.

29.

Hepatocellular carcinoma with carcinoid features.

Barsky SH, Linnoila I, Triche TJ, Costa J.

Hum Pathol. 1984 Sep;15(9):892-4.

PMID:
6147306
30.
31.

The effect of aging on extra-adrenal catecholamine storing cells of the rat.

Partanen M, Linnoila I, Hervonent A, Rapoport SI.

Neurobiol Aging. 1984 Summer;5(2):105-10.

PMID:
6493434
32.

Catecholamine-synthesizing enzymes in paraganglia of aged Fischer-344 rats. Immunohistochemistry and fluorescence microscopy.

Partanen M, Rapoport SI, Reis DJ, Joh TH, Stolk JM, Linnoila I, Teitelman G, Hervonen A.

Cell Tissue Res. 1984;238(2):217-20.

PMID:
6150762
33.

Localization of [Met5]- and [Leu5]-enkephalin-like immunoreactivity in nerve terminals in human paravertebral sympathetic ganglia.

Hervonen A, Linnoila I, Pickel VM, Helén P, Pelto-Huikko M, Alho H, Miller RJ.

Neuroscience. 1981;6(3):323-30. No abstract available.

PMID:
7012666
34.

Immunohistochemical localization of the catecholamine-synthesizing enzymes, substance P and enkephalin in the human fetal sympathetic ganglion.

Hervonen A, Pickel VM, Joh TH, Reis DJ, Linnoila I, Miller RJ.

Cell Tissue Res. 1981;214(1):33-42.

PMID:
6162566
35.

Ultrastructural localization of enkephalin-like immunoreactivity in the rat adrenal medulla.

Hervonen A, Pelto-Huikko M, Linnoila I.

Am J Anat. 1980 Apr;157(4):445-8.

PMID:
6996471
36.

Localization of (Met5)- and (Leu5)-enkephalin in nerve terminals and SIF cells in adult human sympathetic ganglia.

Pelto-Huikko M, Hervonen A, Helen P, Linnoila I, Pickel VM, Miller RJ.

Adv Biochem Psychopharmacol. 1980;25:379-83. No abstract available.

PMID:
7004112
38.

Immunocytochemical demonstration of the catecholamine-synthesizing enzymes and neuropeptides in the catecholamine-storing cells of human fetal sympathetic nervous system.

Hervonen A, Pickel VM, Joh TH, Reis DJ, Linnoila I, Kanerva L, Miller RJ.

Adv Biochem Psychopharmacol. 1980;25:373-8. No abstract available.

PMID:
6160735
39.

Coupling of amines to and cross-linking of endogenous cytosol or membrane proteins by hepatic transglutaminase.

Linnoila I, Abe T, Voytek P, DiAugustine RP.

Biochem Pharmacol. 1979 May 15;28(10):1601-8. No abstract available.

PMID:
38791
40.
41.

Electrophysiological studies on rabbits in long-term exposure to carbon disulfide.

Seppäläinen AM, Linnoila I.

Scand J Work Environ Health. 1975 Sep;1(3):178-83.

42.

Histochemically demonstrable non-specific cholinesterase as an indicator of peripheral nerve lesion in carbon disulphide-induced polyneuropathy.

Juntunen J, Haltia M, Linnoila I.

Acta Neuropathol. 1974;29(4):361-6. No abstract available.

PMID:
4374863

Supplemental Content

Loading ...
Support Center